Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Oxazolidinones from P&U with broad-spectrum antibacterial activity

Feb. 9, 1999

New antiviral agents from SB for herpesvirus infections

Feb. 9, 1999

Novel semisynthetic macrolide antibiotics developed at Abbott

Feb. 5, 1999

Pediatric use of Maxipime approved by the FDA

Feb. 3, 1999

9a-Azalides with potent antibacterial activity in development at Merck

Feb. 2, 1999

Bayer describes new oxazolidinone antibacterials in recently issued patent

Feb. 2, 1999

Regulatory plans for gatifloxacin outlined by Kyorin

Feb. 1, 1999

Daiichi patents broad-spectrum antibacterial series

Feb. 1, 1999

Canadian company formed to develop nucleic acid-based antiinfective drugs

Jan. 29, 1999

FDA advisory committee scheduled to discuss Relenza NDA

Jan. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...